vs
DHI GROUP, INC.（DHX）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
DHI GROUP, INC.的季度营收约是ROCKWELL MEDICAL, INC.的1.7倍（$31.4M vs $18.3M），DHI GROUP, INC.净利率更高（3.0% vs -3.0%，领先6.1%），DHI GROUP, INC.同比增速更快（-9.8% vs -25.6%），DHI GROUP, INC.自由现金流更多（$5.7M vs $2.2M），过去两年DHI GROUP, INC.的营收复合增速更高（-6.7% vs -10.1%）
DHI集团是总部位于丹麦的国际水环境企业，业务涵盖水环境软件开发与工程咨询，拥有自主水环境建模软件MIKE Powered by DHI，同时为客户提供商业应用、数据门户、运营服务等全链条水环境解决方案。集团目前在全球设有30个分支机构，在新加坡和丹麦都设有研发中心，全球员工约1050名。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
DHX vs RMTI — 直观对比
营收规模更大
DHX
是对方的1.7倍
$18.3M
营收增速更快
DHX
高出15.8%
-25.6%
净利率更高
DHX
高出6.1%
-3.0%
自由现金流更多
DHX
多$3.5M
$2.2M
两年增速更快
DHX
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.4M | $18.3M |
| 净利润 | $951.0K | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | 10.4% | -2.2% |
| 净利率 | 3.0% | -3.0% |
| 营收同比 | -9.8% | -25.6% |
| 净利润同比 | -6.9% | 26.7% |
| 每股收益（稀释后） | $0.03 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHXRMTI
| Q4 25 | $31.4M | $18.3M | ||
| Q3 25 | $32.1M | $15.9M | ||
| Q2 25 | $32.0M | $16.1M | ||
| Q1 25 | $32.3M | $18.9M | ||
| Q4 24 | $34.8M | $24.7M | ||
| Q3 24 | $35.3M | $28.3M | ||
| Q2 24 | $35.8M | $25.8M | ||
| Q1 24 | $36.0M | $22.7M |
净利润DHXRMTI
| Q4 25 | $951.0K | $-554.0K | ||
| Q3 25 | $-4.3M | $-1.8M | ||
| Q2 25 | $-841.0K | $-1.5M | ||
| Q1 25 | $-9.4M | $-1.5M | ||
| Q4 24 | $1.0M | $-756.0K | ||
| Q3 24 | $-200.0K | $1.7M | ||
| Q2 24 | $943.0K | $343.0K | ||
| Q1 24 | $-1.5M | $-1.7M |
毛利率DHXRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | 85.7% | 14.3% | ||
| Q2 25 | 84.0% | 15.6% | ||
| Q1 25 | 83.4% | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 85.6% | 22.0% | ||
| Q2 24 | 85.5% | 17.6% | ||
| Q1 24 | 86.5% | 13.5% |
营业利润率DHXRMTI
| Q4 25 | 10.4% | -2.2% | ||
| Q3 25 | -14.0% | -9.9% | ||
| Q2 25 | -3.9% | -8.4% | ||
| Q1 25 | -27.5% | -7.2% | ||
| Q4 24 | 5.0% | -2.1% | ||
| Q3 24 | 1.8% | 6.8% | ||
| Q2 24 | 5.6% | 2.0% | ||
| Q1 24 | 5.5% | -5.8% |
净利率DHXRMTI
| Q4 25 | 3.0% | -3.0% | ||
| Q3 25 | -13.3% | -11.0% | ||
| Q2 25 | -2.6% | -9.3% | ||
| Q1 25 | -28.9% | -8.0% | ||
| Q4 24 | 2.9% | -3.1% | ||
| Q3 24 | -0.6% | 5.9% | ||
| Q2 24 | 2.6% | 1.3% | ||
| Q1 24 | -4.2% | -7.6% |
每股收益（稀释后）DHXRMTI
| Q4 25 | $0.03 | $-0.01 | ||
| Q3 25 | $-0.10 | $-0.05 | ||
| Q2 25 | $-0.02 | $-0.05 | ||
| Q1 25 | $-0.21 | $-0.04 | ||
| Q4 24 | $0.02 | $-0.02 | ||
| Q3 24 | $0.00 | $0.04 | ||
| Q2 24 | $0.02 | $0.01 | ||
| Q1 24 | $-0.03 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.9M | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.5M | $37.0M |
| 总资产 | $188.2M | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHXRMTI
| Q4 25 | $2.9M | $10.7M | ||
| Q3 25 | $2.3M | $13.6M | ||
| Q2 25 | $2.8M | $12.5M | ||
| Q1 25 | $2.7M | $11.4M | ||
| Q4 24 | $3.7M | $15.7M | ||
| Q3 24 | $2.1M | $12.3M | ||
| Q2 24 | $3.0M | $11.9M | ||
| Q1 24 | $3.2M | $6.6M |
总债务DHXRMTI
| Q4 25 | — | — | ||
| Q3 25 | $30.0M | — | ||
| Q2 25 | $30.0M | — | ||
| Q1 25 | $33.0M | — | ||
| Q4 24 | $32.0M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $35.0M | — | ||
| Q1 24 | $41.0M | — |
股东权益DHXRMTI
| Q4 25 | $94.5M | $37.0M | ||
| Q3 25 | $97.3M | $37.0M | ||
| Q2 25 | $102.5M | $30.4M | ||
| Q1 25 | $103.9M | $31.5M | ||
| Q4 24 | $114.3M | $32.6M | ||
| Q3 24 | $111.3M | $29.1M | ||
| Q2 24 | $109.8M | $23.5M | ||
| Q1 24 | $106.6M | $20.6M |
总资产DHXRMTI
| Q4 25 | $188.2M | $57.1M | ||
| Q3 25 | $192.5M | $57.5M | ||
| Q2 25 | $204.9M | $52.6M | ||
| Q1 25 | $212.1M | $54.0M | ||
| Q4 24 | $221.4M | $59.2M | ||
| Q3 24 | $219.4M | $57.1M | ||
| Q2 24 | $224.4M | $53.0M | ||
| Q1 24 | $231.9M | $50.7M |
负债/权益比DHXRMTI
| Q4 25 | — | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.2M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | $2.2M |
| 自由现金流率自由现金流/营收 | 18.1% | 12.0% |
| 资本支出强度资本支出/营收 | 4.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 7.60× | — |
| 过去12个月自由现金流最近4个季度 | $13.8M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流DHXRMTI
| Q4 25 | $7.2M | $2.3M | ||
| Q3 25 | $4.8M | $-1.3M | ||
| Q2 25 | $6.9M | $1.8M | ||
| Q1 25 | $2.2M | $-3.5M | ||
| Q4 24 | $4.4M | $865.0K | ||
| Q3 24 | $5.5M | $4.3M | ||
| Q2 24 | $9.1M | $1.4M | ||
| Q1 24 | $2.1M | $-2.4M |
自由现金流DHXRMTI
| Q4 25 | $5.7M | $2.2M | ||
| Q3 25 | $3.2M | $-1.5M | ||
| Q2 25 | $4.8M | $1.7M | ||
| Q1 25 | $88.0K | $-3.5M | ||
| Q4 24 | $1.6M | $470.0K | ||
| Q3 24 | $2.3M | $4.1M | ||
| Q2 24 | $5.6M | $1.2M | ||
| Q1 24 | $-2.4M | $-2.5M |
自由现金流率DHXRMTI
| Q4 25 | 18.1% | 12.0% | ||
| Q3 25 | 9.9% | -9.6% | ||
| Q2 25 | 15.1% | 10.5% | ||
| Q1 25 | 0.3% | -18.8% | ||
| Q4 24 | 4.6% | 1.9% | ||
| Q3 24 | 6.5% | 14.4% | ||
| Q2 24 | 15.6% | 4.5% | ||
| Q1 24 | -6.5% | -11.1% |
资本支出强度DHXRMTI
| Q4 25 | 4.9% | 0.5% | ||
| Q3 25 | 5.0% | 1.4% | ||
| Q2 25 | 6.3% | 1.0% | ||
| Q1 25 | 6.7% | 0.3% | ||
| Q4 24 | 8.0% | 1.6% | ||
| Q3 24 | 9.2% | 0.7% | ||
| Q2 24 | 9.7% | 1.1% | ||
| Q1 24 | 12.3% | 0.6% |
现金转化率DHXRMTI
| Q4 25 | 7.60× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 9.61× | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHX
| Clearance Jobs | $17.4M | 56% |
| Clearance Jobs Segment | $13.9M | 44% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
